Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-03

Clinical Trial Update: Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine [Phase 3]

View source ↗

Summary

Phase 3 trial update on the efficacy and safety of a fixed-dose combination of olmesartan and amlodipine for hypertension. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benicar (olmesartan) (olmesartan medoxomil)
  • Norvasc (amlodipine) (amlodipine)

Snippet

Sponsor: Institut für Pharmakologie und Präventive Medizin | Conditions: Hypertension | Phase 3 | Status: COMPLETED